LLY
1,023.96
+0.31%↑
JNJ
196.01
+0.34%↑
ABBV
232.37
0%↓
UNH
321.37
-3.25%↓
AZN
89.14
+0.64%↑
LLY
1,023.96
+0.31%↑
JNJ
196.01
+0.34%↑
ABBV
232.37
0%↓
UNH
321.37
-3.25%↓
AZN
89.14
+0.64%↑
LLY
1,023.96
+0.31%↑
JNJ
196.01
+0.34%↑
ABBV
232.37
0%↓
UNH
321.37
-3.25%↓
AZN
89.14
+0.64%↑
LLY
1,023.96
+0.31%↑
JNJ
196.01
+0.34%↑
ABBV
232.37
0%↓
UNH
321.37
-3.25%↓
AZN
89.14
+0.64%↑
LLY
1,023.96
+0.31%↑
JNJ
196.01
+0.34%↑
ABBV
232.37
0%↓
UNH
321.37
-3.25%↓
AZN
89.14
+0.64%↑
24h
Current
Min
217.51
Max
217.99
Recommendations | Buy |
|---|---|
12 Months Forecast | -10.28% downside |
By Acuity
58%
42%
147 / 374 Ranking in Healthcare
By Trading Central
Confidence
Bearish Evidence
18.88 / 19.67 Support & Resistance
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
14 lis 2025, 12:31 UTC
Merck to Buy Cidara Therapeutics in $9.2 Billion Deal -- Update
DJ
Read
14 lis 2025, 12:16 UTC
Merck to Buy Cidara Therapeutics in $9.2 Billion Deal
DJ
Read
14 lis 2025, 11:20 UTC
Cidara Shares Nearly Double Premarket on Report of Takeover by Merck
DJ
Read
14 lis 2025, 11:11 UTC
Merck Nears $9.2 Billion Deal for Cidara, FT Reports, Citing Sources
DJ
Read
23 cze 2025, 12:05 UTC
Cidara Shares Soar Premarket After Positive Influenza Trial Results
DJ
Read
14 lis 2025, 16:30 UTC
Merck Is Paying Up for Flu Biotech as M&A Spree Continues -- Barrons.com
DJ
Read
14 lis 2025, 13:19 UTC
This Biotech Stock Is Soaring 100%. Merck Is Buying It. -- Barrons.com
DJ
Read
14 lis 2025, 12:22 UTC
Pharma Sector Becoming Bidding Battlefield -- Market Talk
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 195.33 USD -10.28%
High 221.5 USD
Low 167 USD
Based on 8 Wall Street analysts offering 12 month price targets forCIDARA THERAPEUTICS INC - Dist in the last 3 months.
By TipRanks
Buy
8 ratings
4
Buy
4
Hold
0
Sell
Based on 8 analysts giving stock ratings to CIDARA THERAPEUTICS INC - Dist in the past 3 months.
By Trading Central
Short Term
Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Strong Bearish Evidence
All events are bearish.
Long Term
Strong Bullish Evidence
All events are bullish.
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
$